Oncoloxía médica

2017

1. A PAM50-based chemoendocrine score for hormone receptor-positive breast cancer with an intermediate risk of relapse

   Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3035-3044

2. A consensus statement on the gender perspective in lung cancer

   Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 527-535

3. A definition for aggressive disease in patients with HER-2 negative metastatic breast cancer: an expert consensus of the Spanish Society of Medical Oncology (SEOM)

   Clinical and Translational Oncology, Vol. 19, Núm. 5, pp. 616-624

4. A high-resolution map of transcriptional repression

   eLife, Vol. 6

5. A phase I study of the SRC kinase inhibitor dasatinib with trastuzumab and paclitaxel as first line therapy for patients with HER2-overexpressing advanced breast cancer. GEICAM/2010-04 study

   Oncotarget, Vol. 8, Núm. 42, pp. 73144-73153

6. A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

   Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1517-1522

7. An assessment of morphometric characteristics of the greater palatine canal using cone beam computed tomography

   Computed Tomography: Advances in Research and Applications (Nova Science Publishers, Inc.), pp. 67-87

8. Anatomical variations of the greater palatine canal in cone-beam computed tomography

   Surgical and Radiologic Anatomy, Vol. 39, Núm. 7, pp. 717-723

9. Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: A multi-institution correlative biomarker study

   Annals of Oncology, Vol. 28, Núm. 7, pp. 1-9

10. Anti-PD-1/PD-L1-induced psoriasis from an oncological perspective

    Journal of the European Academy of Dermatology and Venereology

11. Anti-folate receptor-α IgE but not IgG recruits macrophages to attack tumors via TNFa/MCP-1 signaling

    Cancer Research, Vol. 77, Núm. 5, pp. 1127-1141

12. Assessment of HER2 status in resected gastric cancer in European population

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, pp. iii15

13. Bioética y oncología: una puerta abierta a la oportunidad

    Sociedad Oncológica de Galicia

14. Breast cancer chemoprevention: What and when?

    Cancer and Chemotherapy Reviews, Vol. 12, Núm. 2, pp. 46-57

15. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma

    International Journal of Cancer, Vol. 140, Núm. 7, pp. 1551-1563

16. Clinical management of epidermal growth factor receptor mutation-positive non-small cell lung cancer patients after progression on previous epidermal growth factor receptor tyrosine kinase inhibitors: The necessity of repeated molecular analysis

    Translational Lung Cancer Research, Vol. 6, pp. S21-S34

17. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain

    Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681

18. Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

    APMIS

19. Development of psoriatic arthritis during nivolumab therapy for metastatic non-small cell lung cancer, clinical outcome analysis and review of the literature

    Lung Cancer, Vol. 108, pp. 217-221

20. ERAP1 and HLA-C interaction in inflammatory bowel disease in the Spanish population

    Innate Immunity, Vol. 23, Núm. 5, pp. 476-481